Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04985903 · ClinicalTrials.gov registry record · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
A NA study of Pregnancy and Smoking Cessation, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 840
- Enrollment target
- 1
- Study location
NCT04985903: Recruiting NA study of Pregnancy and Smoking Cessation, sponsored by Duke University.
NCT04985903 is a NA study of Pregnancy and Smoking Cessation that is actively recruiting participants, run by Duke University. The registered enrollment target is 840 participants, roughly in line with the 868-participant average among 191 other Pregnancy trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04985903, a NA study of Pregnancy and Smoking Cessation, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 840 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to conduct a combined intervention that pairs SMS smoking cessation messages for patients with individualized training for OB clinicians to improve quit rates among pregnant smoking. The aim is to determine the effect of the intervention versus control on smoking cessation outcomes on patient smoking cessation. The investigators will recruit patients at their first OB visit who report smoking at Duke and Pitt. Patients in both the control and intervention arm will receive smoking cessation support messages throughout their pregnancy. OB clinicians in the intervention arm will receive tailored smoking cessation counseling training. Clinicians in both arms will receive a one-time 5 A lecture. The investigators will analyze smoking cessation outcomes and audio recordings. This is a minimal risk study.
Primary Outcome
Biochemically validated (urine cotinine) 7-day point prevalent as defined by urine cotinine levels below 50ng/ML.
Conditions Studied
Interventions
- BEHAVIORAL Clinician Communication Intervention
- OTHER 5A's lecture
Study Locations (1)
North Carolina
- Durham OB - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 840 participants |
| Start Date | 2022-03-25 |
| Est. Completion | 2026-02-27 |
| Phase | NA |
What NCT04985903 shows while recruiting
NCT04985903 is an interventional study that assigns participants to a tested intervention. The registered 840 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 868-participant average among 191 other Pregnancy trials with a reported enrollment target.
The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Clinician Communication Intervention is the first listed.
NCT04985903 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04985903 about?
NCT04985903 is a clinical study titled "Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women". The investigators propose to conduct a combined intervention that pairs SMS smoking cessation messages for patients with individualized training for OB clinicians to improve quit rates among pregnant smoking. The aim is to determine the effect of the intervention versus control on smoking cessation ...
What is the current status of trial NCT04985903?
This trial is currently recruiting. It is a NA study. The enrollment target is 840 participants. The study started on 2022-03-25. Estimated completion is 2026-02-27.
What conditions does trial NCT04985903 study?
This clinical trial studies the following conditions: Pregnancy, Smoking Cessation, Communication Research.
What interventions are being tested in trial NCT04985903?
The interventions under investigation include: Clinician Communication Intervention (BEHAVIORAL), 5A's lecture (OTHER).
Who is sponsoring clinical trial NCT04985903?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04985903 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04985903's enrollment target sits among peer trials
840 32nd of 191 higher than 160 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04831580 · 840 participants · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT05384626 · 840 participants · Phase 1
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- NCT06197997 · 840 participants · NA
Resilient, Engaged, and Connected Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI